RT Journal Article SR Electronic T1 Initiation of subcutaneous infliximab (Remsima) therapy for the treatment of inflammatory bowel disease during the COVID-19 pandemic JF Frontline Gastroenterology JO Frontline Gastroenterol FD BMJ Publishing Group Ltd SP 89 OP 90 DO 10.1136/flgastro-2020-101760 VO 13 IS 1 A1 McGoran, John A1 Wilson, Alan A1 McErlain, Shannan A1 Kennedy, Noreen A1 Masterson, Caroline A1 Collins, Caroline A1 Morrison, Graham YR 2022 UL http://fg.bmj.com/content/13/1/89.abstract AB